 Jillian Cotter
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 16 | 2026 | 636 | 4.910 |
Why?
| | Community-Acquired Infections | 12 | 2026 | 177 | 4.560 |
Why?
| | Anti-Bacterial Agents | 16 | 2026 | 1925 | 3.110 |
Why?
| | Hospitals, Pediatric | 16 | 2025 | 558 | 2.410 |
Why?
| | Clostridium Infections | 2 | 2024 | 74 | 1.330 |
Why?
| | Respiratory Tract Infections | 6 | 2025 | 396 | 1.150 |
Why?
| | Child | 46 | 2026 | 22740 | 1.140 |
Why?
| | Hospitalization | 13 | 2026 | 2461 | 1.130 |
Why?
| | Feces | 3 | 2023 | 496 | 1.060 |
Why?
| | Length of Stay | 7 | 2024 | 1350 | 1.030 |
Why?
| | Infant | 24 | 2026 | 10091 | 0.880 |
Why?
| | Communicable Diseases | 3 | 2023 | 166 | 0.850 |
Why?
| | Gastroenteritis | 2 | 2023 | 63 | 0.820 |
Why?
| | Catheterization, Peripheral | 1 | 2025 | 120 | 0.820 |
Why?
| | Child, Preschool | 21 | 2026 | 11868 | 0.810 |
Why?
| | Soft Tissue Infections | 2 | 2021 | 40 | 0.790 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2021 | 56 | 0.790 |
Why?
| | Retrospective Studies | 27 | 2026 | 17330 | 0.780 |
Why?
| | Administration, Intravenous | 4 | 2025 | 172 | 0.770 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 413 | 0.770 |
Why?
| | Diagnostic Tests, Routine | 1 | 2024 | 107 | 0.760 |
Why?
| | Asthma | 4 | 2024 | 1797 | 0.750 |
Why?
| | Administration, Oral | 4 | 2026 | 867 | 0.730 |
Why?
| | Urinary Tract Infections | 2 | 2024 | 210 | 0.730 |
Why?
| | Antimicrobial Stewardship | 2 | 2021 | 130 | 0.690 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 113 | 0.670 |
Why?
| | Cholangitis, Sclerosing | 2 | 2018 | 61 | 0.630 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 327 | 0.620 |
Why?
| | Dexamethasone | 2 | 2019 | 365 | 0.620 |
Why?
| | Diarrhea | 2 | 2023 | 193 | 0.610 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2019 | 27 | 0.600 |
Why?
| | Patient Readmission | 6 | 2026 | 773 | 0.600 |
Why?
| | Prednisone | 2 | 2019 | 226 | 0.580 |
Why?
| | Healthcare Disparities | 1 | 2026 | 736 | 0.570 |
Why?
| | Liver Function Tests | 2 | 2018 | 105 | 0.560 |
Why?
| | Research Design | 1 | 2025 | 1139 | 0.560 |
Why?
| | Child, Hospitalized | 3 | 2024 | 54 | 0.550 |
Why?
| | Patient Care | 1 | 2019 | 120 | 0.540 |
Why?
| | Pediatricians | 1 | 2019 | 121 | 0.540 |
Why?
| | Humans | 60 | 2026 | 145783 | 0.530 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 222 | 0.520 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 288 | 0.450 |
Why?
| | Practice Patterns, Physicians' | 3 | 2025 | 1372 | 0.450 |
Why?
| | Amoxicillin | 2 | 2025 | 35 | 0.430 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 562 | 0.410 |
Why?
| | Emergency Service, Hospital | 9 | 2025 | 2383 | 0.390 |
Why?
| | Critical Pathways | 2 | 2025 | 111 | 0.390 |
Why?
| | Male | 25 | 2026 | 73011 | 0.390 |
Why?
| | Cross-Sectional Studies | 9 | 2026 | 5925 | 0.380 |
Why?
| | Propensity Score | 3 | 2024 | 377 | 0.380 |
Why?
| | Female | 23 | 2026 | 79045 | 0.340 |
Why?
| | Adolescent | 13 | 2025 | 22577 | 0.330 |
Why?
| | Prospective Studies | 8 | 2023 | 8078 | 0.310 |
Why?
| | Intervertebral Disc Degeneration | 2 | 2014 | 33 | 0.290 |
Why?
| | Influenza, Human | 2 | 2023 | 624 | 0.230 |
Why?
| | Patient Safety | 2 | 2019 | 356 | 0.230 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2025 | 47 | 0.220 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 126 | 0.210 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2014 | 15 | 0.210 |
Why?
| | Thrombocythemia, Essential | 1 | 2014 | 6 | 0.210 |
Why?
| | Diskectomy | 1 | 2014 | 24 | 0.210 |
Why?
| | Polycythemia Vera | 1 | 2014 | 8 | 0.210 |
Why?
| | Primary Myelofibrosis | 1 | 2014 | 8 | 0.210 |
Why?
| | Tennis | 1 | 2014 | 5 | 0.210 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 10 | 0.200 |
Why?
| | Phlebotomy | 1 | 2024 | 22 | 0.200 |
Why?
| | Intervertebral Disc | 1 | 2014 | 36 | 0.200 |
Why?
| | Scurvy | 1 | 2024 | 17 | 0.200 |
Why?
| | Cell Survival | 2 | 2014 | 1104 | 0.200 |
Why?
| | Cannula | 1 | 2024 | 28 | 0.200 |
Why?
| | Treatment Failure | 1 | 2024 | 360 | 0.200 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 186 | 0.190 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2013 | 6 | 0.190 |
Why?
| | Hypertension, Portal | 1 | 2014 | 66 | 0.190 |
Why?
| | Hospitals, Community | 1 | 2024 | 67 | 0.190 |
Why?
| | Inpatients | 2 | 2025 | 553 | 0.190 |
Why?
| | Spinal Fractures | 1 | 2014 | 76 | 0.190 |
Why?
| | Diagnostic Imaging | 1 | 2025 | 337 | 0.190 |
Why?
| | Portal Vein | 1 | 2014 | 117 | 0.180 |
Why?
| | Low Back Pain | 1 | 2014 | 108 | 0.180 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2023 | 81 | 0.180 |
Why?
| | Seizures, Febrile | 1 | 2022 | 23 | 0.180 |
Why?
| | Femur Neck | 1 | 2012 | 62 | 0.180 |
Why?
| | Data Collection | 1 | 2025 | 643 | 0.180 |
Why?
| | Lumbar Vertebrae | 1 | 2014 | 252 | 0.180 |
Why?
| | Curriculum | 2 | 2019 | 1074 | 0.170 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2024 | 181 | 0.170 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2023 | 139 | 0.170 |
Why?
| | Treatment Outcome | 5 | 2024 | 11794 | 0.170 |
Why?
| | Hospital Medicine | 1 | 2022 | 97 | 0.170 |
Why?
| | Viruses | 1 | 2023 | 166 | 0.170 |
Why?
| | Intracranial Aneurysm | 2 | 2008 | 106 | 0.170 |
Why?
| | Fever | 1 | 2022 | 320 | 0.160 |
Why?
| | Clinical Competence | 2 | 2019 | 1247 | 0.160 |
Why?
| | Virus Diseases | 1 | 2023 | 216 | 0.160 |
Why?
| | Aftercare | 1 | 2022 | 222 | 0.160 |
Why?
| | Skin Diseases, Infectious | 1 | 2020 | 13 | 0.160 |
Why?
| | Pseudomonas Infections | 1 | 2022 | 231 | 0.160 |
Why?
| | Infant, Newborn | 4 | 2025 | 6465 | 0.160 |
Why?
| | Endpoint Determination | 1 | 2020 | 85 | 0.150 |
Why?
| | Blood Culture | 1 | 2020 | 27 | 0.150 |
Why?
| | Mentoring | 1 | 2022 | 166 | 0.150 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2933 | 0.150 |
Why?
| | Pulmonologists | 1 | 2019 | 14 | 0.150 |
Why?
| | Bone and Bones | 1 | 2012 | 318 | 0.150 |
Why?
| | Mandatory Reporting | 1 | 2019 | 45 | 0.150 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 435 | 0.150 |
Why?
| | Symptom Flare Up | 1 | 2019 | 37 | 0.150 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 251 | 0.140 |
Why?
| | Rotator Cuff Injuries | 1 | 2019 | 77 | 0.140 |
Why?
| | Drug Substitution | 1 | 2019 | 63 | 0.140 |
Why?
| | Competency-Based Education | 1 | 2019 | 81 | 0.140 |
Why?
| | Respiration, Artificial | 1 | 2024 | 714 | 0.140 |
Why?
| | Immunocompromised Host | 1 | 2019 | 202 | 0.140 |
Why?
| | Biliary Tract | 1 | 2018 | 14 | 0.140 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2018 | 24 | 0.130 |
Why?
| | Otitis Media | 1 | 2020 | 182 | 0.130 |
Why?
| | Arthroscopy | 1 | 2019 | 268 | 0.130 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 782 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1217 | 0.130 |
Why?
| | Consensus | 1 | 2019 | 479 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2019 | 251 | 0.120 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1043 | 0.120 |
Why?
| | Universities | 1 | 2019 | 445 | 0.120 |
Why?
| | Quality Improvement | 1 | 2025 | 1296 | 0.120 |
Why?
| | Pandemics | 2 | 2023 | 1711 | 0.120 |
Why?
| | Sepsis | 1 | 2022 | 664 | 0.120 |
Why?
| | Preleukemia | 1 | 2015 | 2 | 0.120 |
Why?
| | Patient Discharge | 1 | 2022 | 995 | 0.110 |
Why?
| | Schools | 1 | 2018 | 449 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 478 | 0.110 |
Why?
| | Colorado | 3 | 2020 | 4556 | 0.110 |
Why?
| | Incidence | 2 | 2020 | 2934 | 0.110 |
Why?
| | Hospitalists | 1 | 2019 | 267 | 0.110 |
Why?
| | Self Report | 1 | 2019 | 876 | 0.110 |
Why?
| | Quality of Life | 2 | 2023 | 3211 | 0.100 |
Why?
| | Lumbosacral Region | 1 | 2013 | 59 | 0.100 |
Why?
| | Trans-Activators | 1 | 2015 | 396 | 0.090 |
Why?
| | Communication | 1 | 2019 | 977 | 0.090 |
Why?
| | Prevalence | 1 | 2020 | 2875 | 0.090 |
Why?
| | Polymorphism, Genetic | 2 | 2013 | 615 | 0.090 |
Why?
| | Cystic Fibrosis | 1 | 2022 | 1163 | 0.090 |
Why?
| | Medical Errors | 1 | 2013 | 119 | 0.090 |
Why?
| | Intraoperative Complications | 1 | 2013 | 157 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 2015 | 625 | 0.090 |
Why?
| | Spine | 1 | 2013 | 182 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3346 | 0.090 |
Why?
| | Internship and Residency | 2 | 2019 | 1269 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 768 | 0.090 |
Why?
| | Inflammation | 2 | 2008 | 2884 | 0.080 |
Why?
| | Pediatrics | 1 | 2018 | 1125 | 0.080 |
Why?
| | Ambulatory Care | 2 | 2025 | 610 | 0.080 |
Why?
| | Liver Transplantation | 1 | 2017 | 827 | 0.080 |
Why?
| | United States | 5 | 2025 | 16126 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 6085 | 0.070 |
Why?
| | Liver | 1 | 2018 | 1899 | 0.070 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 688 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1737 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 2977 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4302 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 45 | 0.060 |
Why?
| | Disease Progression | 3 | 2019 | 2865 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2008 | 507 | 0.050 |
Why?
| | Azithromycin | 1 | 2025 | 101 | 0.050 |
Why?
| | Aggrecans | 1 | 2014 | 15 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2399 | 0.050 |
Why?
| | Organ Culture Techniques | 1 | 2014 | 154 | 0.050 |
Why?
| | Proteoglycans | 1 | 2014 | 112 | 0.050 |
Why?
| | Fracture Healing | 1 | 2014 | 91 | 0.050 |
Why?
| | Penicillins | 1 | 2023 | 62 | 0.050 |
Why?
| | Uncertainty | 1 | 2024 | 146 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2024 | 365 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 48 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 184 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 108 | 0.040 |
Why?
| | Bone Development | 1 | 2012 | 52 | 0.040 |
Why?
| | Cell Polarity | 1 | 2013 | 137 | 0.040 |
Why?
| | Tensile Strength | 1 | 2012 | 98 | 0.040 |
Why?
| | Cattle | 1 | 2014 | 946 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 169 | 0.040 |
Why?
| | Cadaver | 1 | 2012 | 311 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3916 | 0.040 |
Why?
| | Cell Lineage | 1 | 2013 | 378 | 0.040 |
Why?
| | Goals | 1 | 2022 | 185 | 0.040 |
Why?
| | Outpatients | 1 | 2024 | 447 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 191 | 0.040 |
Why?
| | Mentors | 1 | 2022 | 217 | 0.040 |
Why?
| | Peer Group | 1 | 2022 | 256 | 0.040 |
Why?
| | ROC Curve | 1 | 2022 | 618 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 309 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 467 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 52 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2012 | 494 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 484 | 0.040 |
Why?
| | Regression Analysis | 1 | 2012 | 1001 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2022 | 397 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2013 | 592 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2014 | 892 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2023 | 587 | 0.040 |
Why?
| | Hospitals | 1 | 2024 | 733 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2012 | 860 | 0.040 |
Why?
| | Bone Density | 1 | 2012 | 487 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 910 | 0.030 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 232 | 0.030 |
Why?
| | Chronic Disease | 1 | 2023 | 1812 | 0.030 |
Why?
| | Bacteremia | 1 | 2020 | 222 | 0.030 |
Why?
| | Shoulder Joint | 1 | 2019 | 199 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2019 | 280 | 0.030 |
Why?
| | Range of Motion, Articular | 1 | 2019 | 429 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1036 | 0.030 |
Why?
| | Adult | 4 | 2019 | 40881 | 0.030 |
Why?
| | Japan | 1 | 2017 | 149 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2017 | 185 | 0.030 |
Why?
| | Internationality | 1 | 2017 | 156 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2013 | 1166 | 0.030 |
Why?
| | Animals | 4 | 2015 | 38102 | 0.030 |
Why?
| | Teaching | 1 | 2018 | 237 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2013 | 3130 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2005 | 203 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2013 | 4151 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 770 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 716 | 0.030 |
Why?
| | Fatty Acid Desaturases | 1 | 2005 | 31 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2013 | 2050 | 0.030 |
Why?
| | Arabidopsis Proteins | 1 | 2005 | 76 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2017 | 1300 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1378 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1330 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1547 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2770 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 979 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4568 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2017 | 1723 | 0.020 |
Why?
| | Blotting, Western | 1 | 2005 | 1184 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 36309 | 0.020 |
Why?
| | Mice | 2 | 2015 | 18356 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5993 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2013 | 536 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2123 | 0.020 |
Why?
| | Neurosurgical Procedures | 1 | 2013 | 202 | 0.020 |
Why?
| | Aged | 2 | 2019 | 26217 | 0.020 |
Why?
| | Orthopedics | 1 | 2013 | 175 | 0.020 |
Why?
| | Risk | 1 | 2013 | 923 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 8347 | 0.020 |
Why?
| | Internet | 1 | 2013 | 693 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1857 | 0.020 |
Why?
| | Rupture | 1 | 2008 | 91 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5428 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3752 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2005 | 2805 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 6033 | 0.020 |
Why?
| | Risk Factors | 2 | 2013 | 10919 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2008 | 529 | 0.010 |
Why?
| | Hemodynamics | 1 | 2008 | 1118 | 0.010 |
Why?
| | Sex Factors | 1 | 2008 | 2110 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 1023 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2008 | 956 | 0.010 |
Why?
| | Smoking | 1 | 2008 | 1477 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2444 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1276 | 0.010 |
Why?
|
|
Cotter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|